2012-10-09 00:22:31 - Recently published research from Global Markets Direct, "Orchid Chemicals & Pharmaceuticals Ltd - Product Pipeline Review - 2012", is now available at Fast Market Research

Global Market Direct's pharmaceuticals report, "Orchid Chemicals & Pharmaceuticals Ltd - Product Pipeline Review - 2012" provides data on the Orchid Chemicals & Pharmaceuticals Ltd's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Orchid Chemicals & Pharmaceuticals Ltd's corporate website, SEC filings, investor presentations and featured press releases, both from Orchid Chemicals & Pharmaceuticals Ltd and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

* Orchid Chemicals & Pharmaceuticals Ltd - Brief Orchid Chemicals & Pharmaceuticals Ltd overview including business description, key information and facts, and its

locations and subsidiaries.
* Review of current pipeline of Orchid Chemicals & Pharmaceuticals Ltd human therapeutic division.
* Overview of pipeline therapeutics across various therapy areas.
* Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
* Product profiles for late stage and clinical stage products of Orchid Chemicals & Pharmaceuticals Ltd with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
* Recent updates of the Orchid Chemicals & Pharmaceuticals Ltd's pipeline in the last quarter.
* Key discontinued and dormant projects.
* Latest news and deals relating to the products.


Full Report Details at
- www.fastmr.com/prod/468574_orchid_chemicals_pharmaceuticals_ltd_ ..


Reasons to buy

* Evaluate Orchid Chemicals & Pharmaceuticals Ltd's strategic position with total access to detailed information on its product pipeline.
* Assess the growth potential of Orchid Chemicals & Pharmaceuticals Ltd in its therapy areas of focus.
* Identify new drug targets and therapeutic classes in the Orchid Chemicals & Pharmaceuticals Ltd's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
* Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
* Exploit collaboration and partnership opportunities with Orchid Chemicals & Pharmaceuticals Ltd.
* Avoid Intellectual Property Rights related issues.
* Explore the dormant and discontinued projects of Orchid Chemicals & Pharmaceuticals Ltd and identify potential opportunities in those areas.

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Orchid Chemicals & Pharmaceuticals Ltd Snapshot
Orchid Chemicals & Pharmaceuticals Ltd Overview
Key Information
Key Facts
Orchid Chemicals & Pharmaceuticals Ltd - Research and Development Overview
Key Therapeutic Areas
Orchid Chemicals & Pharmaceuticals Ltd - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Orchid Chemicals & Pharmaceuticals Ltd - Pipeline Products Glance
Orchid Chemicals & Pharmaceuticals Ltd Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Orchid Chemicals & Pharmaceuticals Ltd - Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
Orchid Chemicals & Pharmaceuticals Ltd - Drug Profiles
BLX-1002
Product Description
Mechanism of Action
R&D Progress
Cephalosporin
Product Description
Mechanism of Action
R&D Progress
Dipeptidyl-Peptidase IV inhibitor
Product Description
Mechanism of Action
R&D Progress
Drug For CNS
Product Description
Mechanism of Action
R&D Progress
Drug for Diabetes
Product Description
Mechanism of Action
R&D Progress
Drug For Obesity
Product Description
Mechanism of Action
R&D Progress
OCID-0050
Product Description
Mechanism of Action
R&D Progress
OCID-2987
Product Description
Mechanism of Action
R&D Progress
OCID-4681
Product Description
Mechanism of Action
R&D Progress
OCID-5005
Product Description
Mechanism of Action
R&D Progress
OCID5090
Product Description
Mechanism of Action
R&D Progress
Th1 / Th2 Cytokine Synthase Inhibitor
Product Description
Mechanism of Action
R&D Progress
TNF Alpha Inhibitor
Product Description
Mechanism of Action
R&D Progress
Orchid Chemicals & Pharmaceuticals Ltd - Pipeline Analysis
Orchid Chemicals & Pharmaceuticals Ltd - Pipeline Products by Therapeutic Class
Orchid Chemicals & Pharmaceuticals Ltd - Pipeline Products by Route of Administration
Orchid Chemicals & Pharmaceuticals Ltd - Pipeline Products By Mechanism of Action
Orchid Chemicals & Pharmaceuticals Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Orchid Chemicals & Pharmaceuticals Ltd, Recent Developments
Orchid Chemicals & Pharmaceuticals Ltd- Press Release
Apr 25, 2012: Orchid Pharma Receives FDA Approval For Olanzapine Tablets
Feb 02, 2012: Orchid Pharma Receives FDA Approval For Levofloxacin Tabs ANDA
Jan 02, 2012: Orchid Pharma Reports Successful Completion Of Phase I Study Of OCID 2987
Sep 26, 2009: Orchid Receives FDA Approval For Piperacillin-Tazobactam ANDA
Sep 18, 2009: Orchid Receives Final FDA Nod For Zaleplon Capsules
Aug 13, 2009: Orchid Receives Final FDA Nod For Sumatriptan Tablets
Aug 12, 2009: Orchid Chemicals & Pharmaceuticals Ltd (Orchid) and Schering-Plough Corporation (SGP) Settle Clarinex and Clarinex RediTabs Patent Lawsuits
Jul 03, 2009: Orchid Receives FDA Approval For Amlodipine Besylate Tablets

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=468574&dt=t

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.